期刊文献+

新型抗血小板药物的进展 被引量:5

原文传递
导出
摘要 动脉硬化性血栓性疾病是目前全球范围内致死和致残的重要原因,鉴于血小板的激活和聚集在动脉血栓形成过程中的核心作用,以阿司匹林和氯吡格雷为代表的抗血小板药物在急性冠状动脉(冠脉)综合征(ACS)、缺血性卒中等动脉血栓性疾病的治疗中获得了广泛的应用并被证实能显著改善患者的预后,其中阿司匹林和氯吡格雷双重抗血小板治疗已被公认是ACS及经皮冠脉介入治疗(PCI)患者的标准方法。
出处 《中华内科杂志》 CAS CSCD 北大核心 2011年第9期794-796,共3页 Chinese Journal of Internal Medicine
  • 相关文献

参考文献31

  • 1Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/ non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction ) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol, 2007, 50 : e1-e157.
  • 2Sacco RL, Adams R, Albers G, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke : co-sponsored by the Council on Cardiovascular Radiology and Intervention : the American Academy of Neurology affirms the value of this guideline. Circulation, 2006, 113 : e409-e449.
  • 3King SB 3rd, Smith SC Jr, Hirshfeld JW Jr, et al. 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing Committee. Circulation, 2008, 117 : 261-295.
  • 4Lanas A, Garcia-Rodriguez LA, Arroyo MT, et al. Effect of antiseeretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants. Am J Gastroenterol, 2007, 102:507- 515.
  • 5Ho PM, Maddox TM, Wang L, et al. Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. JAMA, 2009, 301 : 937-944.
  • 6Angiolillo DJ. Variability in responsiveness to oral antiplatelet therapy. Am J Cardiol, 2009,103(3 Suppl) :27A-34A.
  • 7Coccheri S. Antiplatelet drugs-do we need new options? With a reappraisal of direct thromboxane inhibitors. Drugs, 2010, 70 : 887-908.
  • 8Maree AO, Fitzgerald DJ. Variable platelet response to aspirin and clopidogrel in atherothrombotic disease. Circulation, 2007, 115 : 2196-2207.
  • 9Maree AO, Curtin RJ, Chubb A, et al. Cyclooxygenase-1 haplotype modulates platelet response to aspirin. J Thromb Haemost, 2005, 3:2340-2345.
  • 10Simon T, Verstuyft C, Mary-Krause M, et al. Genetic determinants of response to clopidogrel and cardiovascular events. N Engl J Med, 2009, 360: 363-375.

同被引文献45

  • 1European Stroke Organisarion (ESO) Executive Committee;ESO Writing Committee.Guidelines for management of ischaemic stroke and transient ischaemic attack 2008[J]Cerebrovascular Diseases,2008(05):457-507.
  • 2Hill MD;Silver FL;Austin PC.Rate of stroke recurrence in patients with primary intracerebral hemorrhage[J]Stroke,2000(01):123-127.
  • 3He J;Whelton PK;Vu B.Aspirin and risk of hemorrhagic stroke-a meta-analysis of randomized controlled trials[J]Journal of the American Medical Association,1998(22):1930-1935.
  • 4Saloheimo P;Ahonen M;Juvela S.Regular aspirin-use preceding the onset of primary intracerebral hemorrhage is an independent predictor for death[J]Stroke,2006(01):129-133.
  • 5Ishibashi A;Yokokura Y;Adachi H.ls antiplatelet therapy for the prevention of ischemic stroke associated with the prognosis of mtracerebral hemorrhagc[J]Kurume Medical Journal,2008(3-4):71-75.
  • 6Naidech AM;Jovanovic B;Liebling S.Reduced plagelet activity is associated with early clot growth and worse 3-month outcome after intracerebral hemorrhage[J]Stroke,2009(07):2398-2401.
  • 7Naidech AM;Bemstein R;Levasseur K.Platelet activity and outcome after intracerebral hemorrhage[J]Annals of Neurology,2009(03):352-356.
  • 8Huang Y;Cheng Y;Wu J.Cilostazol as an alternative to aspirin after ischaemic stroke:a randomised,double,blind,pilot study[J]Lancet Neurology,2008(06):494-499.
  • 9Eckman MH;Rosand J;Knudsen KA.Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis[J]Stroke,2003(07):1710-1716.
  • 10黄东芳,赵子彦.阿司匹林在高血压中的应用进展[J].山东医药,2008,48(13):116-116. 被引量:7

引证文献5

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部